bendamustine hydrochloride
- RxCUI
- 1114693
- RxNorm name
- bendamustine hydrochloride
- Term type
- PIN
- Status
- Active
- Updated
- 2026-10-06 01:44:41
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 082011
- Active start
- 082011
- Multiple ingredient
- NO
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| bendamustine | 134547 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | bendamustine hydrochloride | 1 | NAMES |
| RxNorm Name | bendamustine hydrochloride | 1 | NAMES |
| TTY | PIN | 1 | ATTRIBUTES |
| SPL_SET_ID | 12 linked values
| 12 | CODES |
| UNII_CODE | 981Y8SX18M | 1 | CODES |
| RxCUI | 1114693 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bendamustine Hydrochloride | BENDAMUSTINE HYDROCHLORIDE | Apotex Corp | 085dd54c-4212-d879-afef-ee52732a48c0 | 2026-09-09 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | Avyxa Pharma, LLC | f359e7c6-d104-457d-a7fe-597c74440353 | 2026-05-14 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| VIVIMUSTA | BENDAMUSTINE HYDROCHLORIDE | Azurity Pharmaceuticals, Inc. | 4df6548f-c4ad-4eb2-a54f-19766a3d90ca | 2025-04-03 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | Baxter Healthcare Corporation | 766b73e2-49bb-47f9-bbb1-44cfa1a3197e | 2025-02-10 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| BELRAPZO | BENDAMUSTINE HYDROCHLORIDE | Eagle Pharmaceuticals, Inc | 9759a4ae-82ca-40cf-9c02-e1cadb21cbdc | 2024-09-23 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| bendamustine hydrochloride | BENDAMUSTINE HYDROCHLORIDE | Accord Healthcare, Inc. | 33867f0f-f317-1fd0-e054-00144ff8d46c | 2024-07-18 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| bendamustine hydrochloride | BENDAMUSTINE HYDROCHLORIDE | BluePoint Laboratories | 0df025d2-c093-427a-b599-f605e71fe835 | 2024-03-29 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| VIVIMUSTA | BENDAMUSTINE HYDROCHLORIDE | Slayback Pharma LLC | cbcc6eb7-aa62-4599-af49-05203fedb4bb | 2024-02-27 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| Bendeka | BENDAMUSTINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | ace9a43b-f9bd-4896-abfe-0ef4fec67ddf | 2024-01-19 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | Eugia US LLC | dbe34bc1-06b2-493f-8859-e8b143357aa8 | 2023-07-05 | Warnings, Adverse reactions | BENDAMUSTINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | L01AA | Nitrogen mustard analogues | ATC1-4 | bendamustine | |
| FDASPL | N0000175558 | Alkylating Drug | EPC | has_epc | bendamustine |
| FDASPL | N0000000236 | Alkylating Activity | MOA | has_moa | bendamustine |
| MEDRT | D000069461 | Bendamustine Hydrochloride | CHEM | has_ingredient | bendamustine hydrochloride |
| MEDRT | D000069461 | Bendamustine Hydrochloride | CHEM | has_ingredient | bendamustine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bendamustine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bendamustine |
| MEDRT | D007945 | Leukemia, Lymphoid | DISEASE | may_treat | bendamustine hydrochloride |
| MEDRT | D007945 | Leukemia, Lymphoid | DISEASE | may_treat | bendamustine |
| MEDRT | D008228 | Lymphoma, Non-Hodgkin | DISEASE | may_treat | bendamustine hydrochloride |
| MEDRT | D008228 | Lymphoma, Non-Hodgkin | DISEASE | may_treat | bendamustine |
| MEDRT | N0000000236 | Alkylating Activity | MOA | has_moa | bendamustine hydrochloride |
| MEDRT | N0000000236 | Alkylating Activity | MOA | has_moa | bendamustine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | SNOMEDCT | 430082006 |
| CODES | USP | m4450 |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |